Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia
Clinical trial NCT05592015 · RECRUITING
Trial details
- NCT number
- NCT05592015
- Sponsor
- Jonathan Brammer
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-03
- Primary completion
- 2026-07-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.